集泰股份(002909) - 2021 Q3 - 季度财报

Financial Performance - The company's revenue for Q3 2021 reached ¥429,696,367.93, an increase of 21.56% compared to the same period last year, and a total revenue of ¥1,235,231,195.11 for the year-to-date, reflecting a growth of 48.79%[4] - The net profit attributable to shareholders for Q3 2021 was ¥9,742,856.12, a decrease of 78.25% year-on-year, with a year-to-date net profit of ¥25,795,253.33, down 72.64%[4] - The basic earnings per share for Q3 2021 was ¥0.025, representing an 81.62% decline compared to the same period last year, while the diluted earnings per share also stood at ¥0.025[4] - The total operating revenue for the period reached ¥1,235,231,195.11, a significant increase from ¥830,186,468.11 in the previous period, representing a growth of approximately 48.7%[28] - The total operating costs amounted to ¥1,201,241,932.21, compared to ¥705,805,201.26 in the prior period, indicating an increase of about 70.4%[28] - In Q3 2021, the company's net profit was CNY 25,555,176.54, a decrease of 73.3% compared to CNY 95,474,611.92 in the same period last year[29] - The total comprehensive income for the period was CNY 25,555,176.54, reflecting a decrease from CNY 95,474,611.92 in the same quarter last year[30] Cash Flow and Liquidity - The company's cash flow from operating activities showed a net outflow of ¥193,061,867.50, a significant decline of 380.45% year-on-year[4] - In Q3 2021, the cash generated from financing activities decreased by 67.27% to RMB 20,360,707.20 due to cash outflows from financing activities[11] - The company reported a total cash inflow from operating activities of CNY 836,203,038.56, compared to CNY 581,263,799.48 in the previous year[33] - The net cash flow from financing activities was CNY 20,360,707.20, a decrease of 67.3% from CNY 62,215,105.70 in the same period last year[34] - The cash and cash equivalents decreased significantly to ¥236,238,447.79 from ¥505,214,939.09, a drop of approximately 53.3%[24] - The cash and cash equivalents at the end of the period were CNY 229,586,897.79, down from CNY 493,911,216.52 at the beginning of the period[34] Assets and Liabilities - Total assets at the end of Q3 2021 amounted to ¥1,760,755,257.29, a 6.77% increase from the end of the previous year, while total equity decreased by 2.20% to ¥841,842,797.22[5] - The total liabilities increased to ¥910,680,362.74 from ¥779,819,495.84 in the previous period, reflecting a rise of approximately 16.7%[26] - The company's equity attributable to shareholders decreased to ¥841,842,797.22 from ¥860,795,882.28, indicating a decline of about 2.5%[26] - Total current liabilities were CNY 708,648,777.62, with short-term borrowings at CNY 204,365,431.71[38] - The company's total liabilities increased, with interest expenses rising to CNY 10,213,490.18 from CNY 8,594,483.10 year-on-year[29] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 12,747, with the largest shareholder, Guangzhou Antai Chemical Co., Ltd., holding 40.06% of shares[13] - The company completed a non-public offering of A-shares in 2020, raising a total of RMB 299,999,988.75, with a net amount of RMB 277,374,785.57 after deducting issuance costs[15] - The total share capital increased from 233,802,773 shares to 266,518,148 shares following the non-public offering[15] - The company repurchased 2,003,800 shares, accounting for 0.75% of the total share capital, with a total transaction amount of RMB 20,200,384.40[16] - The total share capital increased to 372,752,452 shares after the completion of the 2020 annual profit distribution[20] - The second phase of the employee stock ownership plan was approved, with adjustments made to ensure its smooth implementation[18] - The company’s major shareholders include several investment firms, with the top 10 shareholders holding significant stakes[13] - The company’s stock repurchase plan was completed, with shares transferred to the employee stock ownership plan account[19] Research and Development - Research and development expenses for Q3 2021 were ¥48,675,630.76, reflecting a 48.53% increase compared to the previous year, indicating a focus on innovation[10] - Research and development expenses rose to CNY 48,675,630.76, up 48.5% from CNY 32,770,627.65 in the previous year[29] Projects and Investments - The company has invested ¥20,387.48 million in the project for producing 80,000 tons of neutral silicone sealant and 30,000 tons of modified silicone sealant, with a progress rate of 13.62% as of September 30, 2021[21] - The project for producing 15,000 tons of two-component silicone rubber and 8,000 tons of vinyl silicone oil has been completed ahead of schedule, with a planned operational date of December 31, 2021[21] - The company has entrusted ¥19,892.22 million in funds for financial management, with a year-end balance of ¥7,749.39 million and a reported income of ¥186.23 million during the reporting period[22] Audit and Compliance - The company has not audited its Q3 2021 report, which may affect the reliability of the financial data presented[40] - The company executed a retrospective adjustment for the new leasing standard, impacting both assets and liabilities[39]